eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Skull Base

Skull Base, Acoustic Neuroma (Vestibular Schwannoma): Multimedia

Author: Joe Walter Kutz Jr, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center
Coauthor(s): Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development; Brandon Isaacson, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center
Contributor Information and Disclosures

Updated: Sep 24, 2009

Multimedia

This table shows the distribution of presenting s...Media file 1: This table shows the distribution of presenting symptoms, ie, the symptom that brought the patient to a physician and that constituted the patient's chief ailment.
This table shows the distribution of presenting s...

This table shows the distribution of presenting symptoms, ie, the symptom that brought the patient to a physician and that constituted the patient's chief ailment.

A small acoustic neuroma within the internal audi...Media file 2: A small acoustic neuroma within the internal auditory canal is easily observed on postgadolinium MRI.
A small acoustic neuroma within the internal audi...

A small acoustic neuroma within the internal auditory canal is easily observed on postgadolinium MRI.

These large bilateral acoustic neuromas are easil...Media file 3: These large bilateral acoustic neuromas are easily observed on MRI. This patient has neurofibromatosis II. Both tumors were eventually removed, leading to anacusis. Facial nerve function remained entirely normal bilaterally.
These large bilateral acoustic neuromas are easil...

These large bilateral acoustic neuromas are easily observed on MRI. This patient has neurofibromatosis II. Both tumors were eventually removed, leading to anacusis. Facial nerve function remained entirely normal bilaterally.

The nerves of the internal auditory canal as obse...Media file 4: The nerves of the internal auditory canal as observed in a cadaveric dissection are shown. The posterior wall of the internal auditory canal has been removed. F indicates the facial nerve. S is the superior vestibular nerve. VIII indicates the statoacoustic nerve as it leaves the brain stem, and P indicates the posterior ampullary nerve. The hollow arrow points to the posterior lip of the boney porous acusticus, and the solid arrow indicates the position of the vestibule. C indicates the cochlear aqueduct.
The nerves of the internal auditory canal as obse...

The nerves of the internal auditory canal as observed in a cadaveric dissection are shown. The posterior wall of the internal auditory canal has been removed. F indicates the facial nerve. S is the superior vestibular nerve. VIII indicates the statoacoustic nerve as it leaves the brain stem, and P indicates the posterior ampullary nerve. The hollow arrow points to the posterior lip of the boney porous acusticus, and the solid arrow indicates the position of the vestibule. C indicates the cochlear aqueduct.

The bone that must be removed for a middle crania...Media file 5: The bone that must be removed for a middle cranial fossa approach is indicated in yellow. The tumor is in orange.
The bone that must be removed for a middle crania...

The bone that must be removed for a middle cranial fossa approach is indicated in yellow. The tumor is in orange.

The bone that must be removed for a translabyrint...Media file 6: The bone that must be removed for a translabyrinthine approach is indicated in yellow. The tumor is in orange.
The bone that must be removed for a translabyrint...

The bone that must be removed for a translabyrinthine approach is indicated in yellow. The tumor is in orange.

The bone that must be removed for a posterior fos...Media file 7: The bone that must be removed for a posterior fossa approach is indicated in yellow. The tumor is in orange.
The bone that must be removed for a posterior fos...

The bone that must be removed for a posterior fossa approach is indicated in yellow. The tumor is in orange.

More on Skull Base, Acoustic Neuroma (Vestibular Schwannoma)

Overview: Skull Base, Acoustic Neuroma (Vestibular Schwannoma)
Workup: Skull Base, Acoustic Neuroma (Vestibular Schwannoma)
Treatment: Skull Base, Acoustic Neuroma (Vestibular Schwannoma)
Follow-up: Skull Base, Acoustic Neuroma (Vestibular Schwannoma)
Multimedia: Skull Base, Acoustic Neuroma (Vestibular Schwannoma)
References

References

  1. Lin D, Hegarty JL, Fischbein NJ, et al. The prevalence of "incidental" acoustic neuroma. Arch Otolaryngol Head Neck Surg. Mar 2005;131(3):241-4. [Medline].

  2. Telian SA. Management of the small acoustic neuroma: a decision analysis. Am J Otol. May 1994;15(3):358-65. [Medline].

  3. Hansen MR, Clark JJ, Gantz BJ, et al. Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation. Laryngoscope. Jun 2008;118(6):1023-30. [Medline].

  4. Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope. Apr 2000;110(4):497-508. [Medline].

  5. Bance M, Ramsden RT. Management of neurofibromatosis type 2. Ear Nose Throat J. Feb 1999;78(2):91-4, 96. [Medline].

  6. Bederson JB, von Ammon K, Wichmann WW, et al. Conservative treatment of patients with acoustic tumors. Neurosurgery. May 1991;28(5):646-50; discussion 650-1. [Medline].

  7. Brackmann DE, Fisher LM, Hansen M, et al. The effect of famciclovir on delayed facial paralysis after acoustic tumor resection. Laryngoscope. Sep 2008;118(9):1617-20. [Medline].

  8. Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. Jul 1 2007;68(3):845-51. [Medline].

  9. Combs SE, Thilmann C, Debus J, et al. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys. Apr 1 2006;64(5):1341-7. [Medline].

  10. Friedman RA, Brackmann DE, Mills D. Auditory-nerve integrity after middle-fossa acoustic-tumor removal. Otolaryngol Head Neck Surg. Dec 1998;119(6):588-92. [Medline].

  11. Fucci MJ, Buchman CA, Brackmann DE, et al. Acoustic tumor growth: implications for treatment choices. Am J Otol. Jul 1999;20(4):495-9. [Medline].

  12. Glasscock ME 3rd, Pappas DG Jr, Manolidis S, et al. Management of acoustic neuroma in the elderly population. Am J Otol. Mar 1997;18(2):236-41; discussion 241-2. [Medline].

  13. House JW, Kutz JW Jr. Bone-anchored hearing aids: incidence and management of postoperative complications. Otol Neurotol. Feb 2007;28(2):213-7. [Medline].

  14. Isaacson B, Kileny PR, El-Kashlan HK. Prediction of long-term facial nerve outcomes with intraoperative nerve monitoring. Otol Neurotol. Mar 2005;26(2):270-3. [Medline].

  15. Isaacson B, Telian SA, El-Kashlan HK. Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches. Otolaryngol Head Neck Surg. Dec 2005;133(6):906-10. [Medline].

  16. Jackler RK, Pitts LH. Selection of surgical approach to acoustic neuroma. Otolaryngol Clin North Am. Apr 1992;25(2):361-87. [Medline].

  17. Kartush JM. Intra-operative monitoring in acoustic neuroma surgery. Neurol Res. Oct 1998;20(7):593-6. [Medline].

  18. Kondziolka D, Lunsford LD, McLaughlin MR, et al. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med. Nov 12 1998;339(20):1426-33. [Medline].

  19. Lanman TH, Brackmann DE, Hitselberger WE, et al. Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach. J Neurosurg. Apr 1999;90(4):617-23. [Medline].

  20. Lunsford LD, Flickinger J, Coffey RJ. Stereotactic gamma knife radiosurgery. Initial North American experience in 207 patients. Arch Neurol. Feb 1990;47(2):169-75. [Medline].

  21. Magliulo G, Zardo F. Facial nerve function after cerebellopontine angle surgery and prognostic value of intraoperative facial nerve monitoring: a critical evaluation. Am J Otolaryngol. Mar-Apr 1998;19(2):102-6. [Medline].

  22. Moffat DA, da Cruz MJ, Baguley DM, et al. Hearing preservation in solitary vestibular schwannoma surgery using the retrosigmoid approach. Otolaryngol Head Neck Surg. Dec 1999;121(6):781-8. [Medline].

  23. Otto SR, Brackmann DE, Hitselberger WE, et al. Multichannel auditory brainstem implant: update on performance in 61 patients. J Neurosurg. Jun 2002;96(6):1063-71. [Medline].

  24. Pitts LH, Jackler RK. Treatment of acoustic neuromas [editorial; comment]. N Engl J Med. Nov 12 1998;339(20):1471-3. [Medline].

  25. Rauch SD, Xu WZ, Nadol JB Jr. High jugular bulb: implications for posterior fossa neurotologic and cranial base surgery. Ann Otol Rhinol Laryngol. Feb 1993;102(2):100-7. [Medline].

  26. Roland PS, Eston D. Stereotactic radiosurgery of acoustic tumors. Otolaryngol Clin North Am. Apr 2002;35(2):343-55. [Medline].

  27. Roland PS, Gilmore J. Intracochlear schwannoma. Otolaryngol Head Neck Surg. Dec 1998;119(6):681-4. [Medline].

  28. Roland PS, Glasscock ME 3d, Bojrab DI, et al. Normal hearing in patients with acoustic neuroma. South Med J. Feb 1987;80(2):166-9. [Medline].

  29. Roland PS, Marple B. Diagnosis and Management of Acoustic Neuromas. Alexandria, VA: American Academy of Otolaryngology; 1998.

  30. Roland PS, Meyerhoff WL, Balcombe KL, et al. Spinal fluid profile following surgery in the subarachnoid space. Otolaryngol Head Neck Surg. Oct 1989;101(4):445-8. [Medline].

  31. Slattery WH 3rd, Brackmann DE, Hitselberger W. Hearing preservation in neurofibromatosis type 2. Am J Otol. Sep 1998;19(5):638-43. [Medline].

  32. Slattery WH 3rd, Brackmann DE, Hitselberger W. Middle fossa approach for hearing preservation with acoustic neuromas. Am J Otol. Sep 1997;18(5):596-601. [Medline].

  33. Snyder WE, Pritz MB, Smith RR. Suboccipital resection of a medial acoustic neuroma with hearing preservation. Surg Neurol. May 1999;51(5):548-52; discussion 552-3. [Medline].

  34. Tos M, Charabi S, Thomsen JC, et al. [Results of hearing preservation via middle fossa approach in surgery for acoustic neurinoma]. Ugeskr Laeger. Oct 24 1994;156(43):6370-5. [Medline].

  35. Tos M, Stangerup SE, Caye-Thomasen P, et al. What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg. Feb 2004;130(2):216-20. [Medline].

Further Reading

Keywords

acoustic neuroma, vestibular schwannoma, unilateral sensorineural hearing loss, Schwann cells, acoustic tumor, unilateral tinnitus, neurofibromatosis type 2, acoustic schwannoma, tumors, tumor Schwann cell sheath, vestibular nerve, cochlear nerve, cerebellopontine angle 

Contributor Information and Disclosures

Author

Joe Walter Kutz Jr, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center
Joe Walter Kutz Jr, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Neurotology Society, American Neurotology Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Consulting

Brandon Isaacson, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center
Brandon Isaacson, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Neurotology Society, North American Skull Base Society, and Texas Medical Association
Disclosure: Medtronic Midas Rex Insitute Honoraria Speaking and teaching

Medical Editor

Douglas D Backous, MD, Director of Listen for Life Center, Department of Otolaryngology-Head and Neck Surgery, Virginia Mason Medical Center
Douglas D Backous, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Association for Research in Otolaryngology, North American Skull Base Society, Society for Neuroscience, and Washington State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gerard J Gianoli, MD, Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center
Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.